My understanding of the after care of previous trial patients is that they continue to improve. The problem with healing these ulcers is that the natural healing process has somehow been overwhelmed ie non-existant - and what VitoGro does is to trigger wound healing at the perimeter and this process continues after trial concluded. Whether it continues to the point of cure - I don't know - but I do recall one Canadian trial participant for whom the wound did continue to heal completely (post trial completion). Re British trials - they are being conducted in Wound Clinics - we don't have those here. This gives Professor Harding more scope to populate the trial with wounds of disparate severity - possibly a different sort of population than we have seen previously. I believe these trials are rather longer than previously - such as 8 weeks.
All very exciting.
I am not a biochemist nor an analyst - dyor.
TIS Price at posting:
44.4¢ Sentiment: Buy Disclosure: Held
